Pebble Labs Builds Management Team With New Hires

NEW POSITIONS DRIVE INNOVATION, STRATEGY, AND REGULATORY AFFAIRS

LOS ALAMOS, N.M., July 10, 2018 /PRNewswire/ -- Pebble Labs Inc. -- the biotechnology company developing solutions to safely and sustainably eliminate pathogens in aquaculture, agriculture, and vector-borne diseases without the use of herbicides, pesticides or antibiotics -- today announced the appointment of three medical industry executives to its management team.

"Pebble Labs is following the same strategy with our management team hiring that guides our science team build-out - attract and hire only the best, most experienced, highest achieving individuals from throughout the industry and around the world," said Michael Harrison, Chief Executive Officer and Chairman of the Board.

The new appointees are:

    --  Dr. Rick DeRose, Director of Product Innovation -- Dr. DeRose has more
        than 25 years of experience in Ag Biotechnology at Syngenta and Bayer
        developing innovation strategies for R&D projects. He was co-inventor of
        the first commercialized Roundup Ready Corn varieties. Dr. DeRose
        received the ASPB 2017 Innovation Prize for Agricultural Technology for
        successfully translating discovery research into demonstrable,
        real-world outcomes on Global Agriculture, and is an Industry Fellow for
        the Center for Innovation Management Studies at North Carolina State
        University. He received a Ph.D. in Medical Microbiology and Immunology
        from Wake Forest School of Medicine. Dr. DeRose reports to Jon
        Bloodworth, Chief Operating Officer at Pebble Labs.
    --  Dr. Anne Lo, Director of Strategic Development -- Dr. Lo trained as a
        veterinary surgeon and worked in a number of clinical positions. She
        subsequently joined management consulting firm Bain & Co in London,
        before moving to a strategy role with WorldPay. Dr. Lo was most recently
        with Horizons Ventures based in Hong Kong, where she primarily covered
        science and healthcare investments. Dr. Lo received her BSc and BVM&S
        degrees from the University of Edinburgh and Ph.D. from the University
        of Cambridge. Dr. Lo reports to Mr. Harrison.
    --  Dr. Tichafa "Tich" Munyikwa, Director of Regulatory Affairs -- Dr.
        Munyikwa has more than 20 years' experience working in major Ag
        Biotechnology companies in positions as Senior Research Scientist and
        Global Regulatory Expert. He is an inventor with granted worldwide
        scientific patents and a track record of international product
        development and registration. His expertise lies in regulatory policy
        development and advocacy as well as business strategy and
        implementation. Fields covered include: Agribusiness, Biotechnology,
        Plant Molecular and Cell Biology, Biologicals, RNA interference, Genome
        Editing, and Synthetic Biology. Dr. Munyikwa received his Ph.D. in Cell
        and Molecular Biology from Wageningen University (The Netherlands). Dr.
        Munyikwa reports to Mr. Bloodworth.

The Pebble Labs management team is based in Santa Fe and at the New Mexico Consortium at the Los Alamos National Laboratory.

About Pebble Labs

Pebble Labs Inc. is a biotechnology company developing solutions to safely and sustainably eliminate pathogens in aquaculture, agriculture, and vector-borne diseases without the use of herbicides, pesticides or antibiotics.

The approach is a scientific breakthrough leveraging technology and biology developed over the last 10 years at top labs and universities. The solution naturally hinders an organism's ability to replicate targeted viruses via proprietary and patent-pending food-source bacteria designed to block virus replication. This is completely safe for all other organisms--including the targeted organism. The bacteria can be applied cost-effectively in affected areas across the globe.

Pebble Labs uses an innovative "distributed" model for scientific research, collaborating with world class experts in academia and the private sector and retains control over operations and ownership for all core IP. The company coordinates research from one central location (The New Mexico Consortium) and uses world-class facilities at Colorado State University, New Mexico State University, the National Center for Genome Resources, and others for research. This research is supplemented with oversight from a Scientific Advisory Board.

Pebble Labs' divisions apply its technology to aquaculture (Mermaid Bio), agriculture (IronLeaf), and mosquito and vector-borne diseases (LittleFly).

CONTACT:
Thomas Walek
Peaks Strategies
+917-353-7575
twalek@PeaksStrategies.com

View original content:http://www.prnewswire.com/news-releases/pebble-labs-builds-management-team-with-new-hires-300678665.html

SOURCE Pebble Labs Inc.